🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

GameStop CEO undergoes surgery for brain tumor

Published 08/19/2014, 12:06 PM
Updated 08/19/2014, 12:10 PM
GameStop CEO undergoes surgery for brain tumor

(Reuters) - GameStop Corp, the world's largest retailer of videogame products, said Chief Executive Paul Raines underwent an unexpected surgery last week for a small cancerous brain tumor.

Raines, who will be undergoing chemotherapy, will restrict his travel during the expected six week of treatment, the company said in a regulatory filing on Tuesday.

GameStop also said the six-week treatment period will not interfere with Raines' "continued leadership" of the company.

Raines, 50, was GameStop's chief operating officer from September 2008 to June 2010 before moving into his current role, according to the company's website.

The company is unlikely to bring in an interim CEO as Raines' treatment lasts only weeks and not months, Wedbush Securities analyst Michael Pachter told Reuters in a mail.

Since Raines took over as CEO, GameStop's shares have nearly doubled. But the stock has lost some of those gains this year as game software sales remain weak at a time when the company's used-game business, its most profitable, faces new competition from Wal-Mart.

During the treatment period, some of Raines' duties may be taken over by President Tony Bartel and Chief Financial Officer Rob Lloyd, SunTrust Robinson Humphrey Capital Markets analysts David Magee wrote in a note.

"... We view his (Paul Raines') expected timely return (later this fall) as important to GameStop's ongoing success," Magee added.

The company is scheduled to report second-quarter results on Aug. 21.

© Reuters. The GameStop store sign is seen at its shop in Westminster

GameStop's shares were marginally up at $41.05 by midday. They closed at $40.65 on the New York Stock Exchange on Tuesday.

(Reporting By Lehar Maan in Bangalore; Editing by Joyjeet Das and Saumyadeb Chakrabarty)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.